Asthma COPD overlap: Impact of associated comorbidities

Diego Jose Maselli, Nicola Alexander Hanania

Research output: Contribution to journalReview articlepeer-review

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are common chronic pulmonary conditions worldwide which often coexist. Patients with asthma COPD overlap (ACO) may have worse outcomes than those with either disease alone, for example, more respiratory symptoms and frequent exacerbations, and worse lung function. Additionally, there is a growing interest in factors that affect the disease including comorbid conditions. Indeed, recent studies have demonstrated higher rates of comorbid conditions in the ACO population, but the mechanisms behind these observations remain unclear. The objective of this review is to describe current knowledge and clinical implications of the overlapping features of asthma and COPD, and discuss the prevalence and impact of comorbidities, such as osteoporosis, cardiovascular disease, gastroesophageal reflux disease, and depression, in this subgroup of patients.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalPulmonary Pharmacology and Therapeutics
Volume52
DOIs
StatePublished - Oct 2018

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Asthma COPD overlap: Impact of associated comorbidities'. Together they form a unique fingerprint.

Cite this